Market Overview:
The global infertility market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth can be attributed to the increasing prevalence of infertility, rising awareness about assisted reproductive technologies (ART), and technological advancements in ART procedures. The global infertility market is segmented by type, application, and region. By type, the market is divided into assisted reproductive technology (ART), artificial insemination, and fertility surgeries. By application, the market is classified into male and female infertility. Geographically, the global infertility market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . In 2017 North America held the largest share of the global infertility Market followed by Europe .
Product Definition:
Infertility can be defined as the inability to conceive a child or the inability of a woman to carry a pregnancy to full term. Infertility is a common problem that affects about 15 percent of couples in the United States. The importance of infertility lies in its ability to cause emotional and physical stress for those affected by it.
Assisted Reproductive Technology (ART):
According to the American Society for Reproductive Medicine, in U.S., infertility affects around 12% of couples of reproductive age and is more common among women. The global fertility rate has been continuously declining since 1980s and this trend is expected to continue owing to lifestyle changes such as smoking, alcohol consumption, obesity & stress which are leading cause various hormonal imbalance in men and women.
Artificial Insemination:
Artificial Insemination (AI) is a procedure where the husband or partner's sperm is injected into the wife's ovary to create pregnancy. It is also known as in-vitro fertilization (IVF), and can be done with the husband's consent, with or without his knowledge.
The process of artificial insemination for infertility treatment has advanced significantly over recent years.
Application Insights:
The male application segment held the largest share of over 70.0% in 2017. This is attributed to the high prevalence of male infertility and increasing number of procedures for semen analysis. According to a study published by WHO, around 1,000,000 men above 40 years have low sperm count which requires medical attention. Thus rising demand for assisted reproductive technology (ART) in order to improve semen quality is expected to boost market growth during the forecast period.
On the other hand, female application segment is expected register significant growth owing to increase in adoption of modern contraceptives and rising awareness about fertility problems among women aged between 15-24 years old as reported by UNFPA in its 2016 global survey on sexual education, health & rights.
Regional Analysis:
Europe dominated the global market in terms of revenue share in 2017. The fertility rate in Europe has been decreasing over the years and reached a historic low of 1.51 children per woman, according to Eurostat data published in 2018. This is attributed to various factors such as late childbearing, single-parent households, rising divorce rates and increasing age at marriage among others.
Growth Factors:
- Increasing awareness about infertility and its treatment options.
- Growing number of couples seeking fertility treatments.
- Advances in reproductive technologies and treatments options.
- Rise in the number of women postponing pregnancy to later in life due to career or other reasons .
Scope Of The Report
Report Attributes
Report Details
Report Title
Infertility Market Research Report
By Type
Assisted Reproductive Technology (ART), Artificial Insemination, Fertility Surgeries
By Application
Male, Female
By Companies
The Cooper Companies, Cook Group, Thermo Fisher Scientific, Vitrolife, Esco Micro, Genea, Irvine Scientific, Ivftech, The Baker Company, Kitazato, Rinovum Women’s Health, Rocket Medical, Ihmedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Infertility Market Report Segments:
The global Infertility market is segmented on the basis of:
Types
Assisted Reproductive Technology (ART), Artificial Insemination, Fertility Surgeries
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Male, Female
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- The Cooper Companies
- Cook Group
- Thermo Fisher Scientific
- Vitrolife
- Esco Micro
- Genea
- Irvine Scientific
- Ivftech
- The Baker Company
- Kitazato
- Rinovum Women’s Health
- Rocket Medical
- Ihmedical
Highlights of The Infertility Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Assisted Reproductive Technology (ART)
- Artificial Insemination
- Fertility Surgeries
- By Application:
- Male
- Female
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infertility Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infertility is a condition in which a couple cannot conceive a child.
Some of the key players operating in the infertility market are The Cooper Companies, Cook Group, Thermo Fisher Scientific, Vitrolife, Esco Micro, Genea, Irvine Scientific, Ivftech, The Baker Company, Kitazato, Rinovum Women¢â‚¬â„¢s Health, Rocket Medical, Ihmedical.
The infertility market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infertility Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infertility Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infertility Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infertility Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infertility Market Size & Forecast, 2018-2028
4.5.1 Infertility Market Size and Y-o-Y Growth
4.5.2 Infertility Market Absolute $ Opportunity
Chapter 5 Global Infertility Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Infertility Market Size Forecast by Type
5.2.1 Assisted Reproductive Technology (ART)
5.2.2 Artificial Insemination
5.2.3 Fertility Surgeries
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Infertility Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Infertility Market Size Forecast by Applications
6.2.1 Male
6.2.2 Female
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infertility Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infertility Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Infertility Analysis and Forecast
9.1 Introduction
9.2 North America Infertility Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Infertility Market Size Forecast by Type
9.6.1 Assisted Reproductive Technology (ART)
9.6.2 Artificial Insemination
9.6.3 Fertility Surgeries
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Infertility Market Size Forecast by Applications
9.10.1 Male
9.10.2 Female
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Infertility Analysis and Forecast
10.1 Introduction
10.2 Europe Infertility Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Infertility Market Size Forecast by Type
10.6.1 Assisted Reproductive Technology (ART)
10.6.2 Artificial Insemination
10.6.3 Fertility Surgeries
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Infertility Market Size Forecast by Applications
10.10.1 Male
10.10.2 Female
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Infertility Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Infertility Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Infertility Market Size Forecast by Type
11.6.1 Assisted Reproductive Technology (ART)
11.6.2 Artificial Insemination
11.6.3 Fertility Surgeries
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Infertility Market Size Forecast by Applications
11.10.1 Male
11.10.2 Female
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Infertility Analysis and Forecast
12.1 Introduction
12.2 Latin America Infertility Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Infertility Market Size Forecast by Type
12.6.1 Assisted Reproductive Technology (ART)
12.6.2 Artificial Insemination
12.6.3 Fertility Surgeries
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Infertility Market Size Forecast by Applications
12.10.1 Male
12.10.2 Female
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Infertility Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Infertility Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Infertility Market Size Forecast by Type
13.6.1 Assisted Reproductive Technology (ART)
13.6.2 Artificial Insemination
13.6.3 Fertility Surgeries
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Infertility Market Size Forecast by Applications
13.10.1 Male
13.10.2 Female
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infertility Market: Competitive Dashboard
14.2 Global Infertility Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 The Cooper Companies
14.3.2 Cook Group
14.3.3 Thermo Fisher Scientific
14.3.4 Vitrolife
14.3.5 Esco Micro
14.3.6 Genea
14.3.7 Irvine Scientific
14.3.8 Ivftech
14.3.9 The Baker Company
14.3.10 Kitazato
14.3.11 Rinovum Women’s Health
14.3.12 Rocket Medical
14.3.13 Ihmedical
